Icon

DROXIA (nda016295)- (200MG,300MG,400MG)

HYDROXYUREA CHEPLAPHARM
200MG,300MG,400MG
No No
Expired Expired
None None
None No
DROXIA is an antimetabolite indicated to reduce the frequency of painful crises and to reduce the need for blood transfusions in patients with sickle cell anemia with recurrent moderate to severe painful crises.
0 0 0
Total Other Developers None
Drugs with Suitability No
200MG ** ** - - -
300MG ** ** - - -
400MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.